Propiedad y actividad de insiders de bioAffinity Technologies, Inc. (BIAF): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $5.35 |
| Capitalización | $2M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2025-08-12 | Rios Roberto | |||
| 2025-08-12 | Oppenheimer John J. | |||
| 2025-01-10 | Reveles Xavier Trinidad | A-Award | 21,604 | |
| 2025-01-10 | GIRGENTI STEVEN | A-Award | 14,814 | |
| 2025-01-10 | Zannes Maria | A-Award | 37,037 | |
| 2025-01-10 | Edwards James Michael | A-Award | 6,172 | |
| 2025-01-10 | Zannes Timothy P | A-Award | 8,641 | |
| 2024-11-05 | Edwards James Michael | A-Award | 100,000 | |
| 2024-09-16 | Edwards James Michael | |||
| 2022-09-01 | Edwards James Michael | 5,876 | $18K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $578483 | $83108 | $1.4M | $11.4M | $2.8M | $1.1M | $6.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $1530 | $1530 | $1530 | $10489 | $811674 | $1.1M | $541962 |
| Inventario | 0 | $28352 | 0 | $5540 | $18484 | $27608 | $53548 |
| Activos Corrientes | $617506 | $118655 | $1.4M | $12.0M | $4.0M | $2.7M | $7.6M |
| Inmovilizado Material | $28804 | $9450 | $4633 | $214438 | $2.0M | $1.6M | $1.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | $1.4M | $1.4M | $1.4M |
| Activos Intangibles | 0 | 0 | 0 | 0 | $833472 | $775139 | $716806 |
| Activos Totales | $658810 | $145605 | $1.5M | $12.2M | $8.2M | $6.5M | $11.0M |
| Cuentas por Pagar | $103418 | $191387 | $230407 | $345042 | $604789 | $987311 | $761901 |
| Deuda a Corto | $4.0M | $10.0M | $11.2M | $251746 | 0 | $171669 | $383871 |
| Pasivos Corrientes | $4.7M | $11.1M | $13.0M | $1.1M | $2.2M | $3.1M | $2.9M |
| Deuda a Largo | 0 | $53466 | $160184 | 0 | 0 | $20180 | $41313 |
| Pasivos Totales | $4.7M | $15.2M | $17.2M | $1.1M | $3.4M | $3.9M | $3.7M |
| Reservas | -$14.9M | -$22.2M | -$28.5M | -$36.7M | -$44.6M | -$53.6M | -$68.6M |
| Patrimonio Neto | -$4.0M | -$15.1M | -$15.8M | $11.0M | $4.9M | $2.6M | $7.3M |
| Deuda Total | $4.0M | $10.0M | $11.4M | $251746 | $1.6M | $1.5M | $1.2M |
| Deuda Neta | $3.4M | $9.9M | $10.0M | -$11.2M | -$1.2M | $395903 | -$5.3M |
| Capital Circulante | -$4.1M | -$11.0M | -$11.6M | $10.8M | $1.7M | -$409807 | $4.7M |
Salud financiera
| Deuda / Patrimonio | 0.38 |
| Ratio corriente | 1.44 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -10.54 |
Rentabilidad
| Rentabilidad sobre capital | -257.27% |
| Rentabilidad sobre capital invertido | -237.93% |
| Rentabilidad sobre activos | -199.30% |
| Margen bruto | -39.57% |
| Margen operativo | -209.82% |
| Margen neto | -257.33% |
Empresas relacionadas: ARTL · CARM · GTBP · LIPO · MNDR · PBM · PTIX
Explorar sector: Healthcare · Medical - Diagnostics & Research
Más secciones de BIAF: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones